Euroapi Company Header Euroapi Company Header

X

CAS 102029-44-7 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 102029-44-7
Also known as: 102029-44-7, (r)-(+)-4-benzyl-2-oxazolidinone, (r)-4-benzyloxazolidin-2-one, (4r)-4-benzyl-1,3-oxazolidin-2-one, 2-oxazolidinone, 4-(phenylmethyl)-, (4r)-, R-4-benzyl-2-oxazolidinone
Molecular Formula
C10H11NO2
Molecular Weight
177.20  g/mol
InChI Key
OJOFMLDBXPDXLQ-SECBINFHSA-N

1 2D Structure

CAS 102029-44-7

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(4R)-4-benzyl-1,3-oxazolidin-2-one
2.1.2 InChI
InChI=1S/C10H11NO2/c12-10-11-9(7-13-10)6-8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H,11,12)/t9-/m1/s1
2.1.3 InChI Key
OJOFMLDBXPDXLQ-SECBINFHSA-N
2.1.4 Canonical SMILES
C1C(NC(=O)O1)CC2=CC=CC=C2
2.1.5 Isomeric SMILES
C1[C@H](NC(=O)O1)CC2=CC=CC=C2
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 102029-44-7

2. (r)-(+)-4-benzyl-2-oxazolidinone

3. (r)-4-benzyloxazolidin-2-one

4. (4r)-4-benzyl-1,3-oxazolidin-2-one

5. 2-oxazolidinone, 4-(phenylmethyl)-, (4r)-

6. R-4-benzyl-2-oxazolidinone

7. (r)-(-)-4-benzyl-2-oxazolidinone

8. (r)-4-benzyl-oxazolidin-2-one

9. R-(-)-4-benzyl-2-oxazolidinone

10. Mfcd00010846

11. 4-benzyl-1,3-oxazolidin-2-one #

12. R-(+)-4-benzyl-2-oxazolidinone

13. Mls001242802

14. 4(r)-benzyl-2-oxazolidinone

15. 4alpha-benzyl-2-oxazolidinone

16. Schembl137215

17. 4-(r)-benzyl-2-oxazolidinone

18. 4-(r)-benzyloxazolidin-2-one

19. (r)-4-benzyl-oxazolidin-2-on

20. (r)-4-benzyloxazolidine-2-one

21. Chembl1366601

22. (r)-4-benzyl Oxazolidin-2-one

23. Dtxsid60370594

24. (r) -4-benzyl-oxazolidin-2-one

25. Hms2205p17

26. (r)-(+)-4-benzyl-2-oxazolidone

27. (r)-(+)4-benzyl-2-oxazolidinone

28. Act01862

29. Bcp22798

30. Zinc4284392

31. Akos005145805

32. Akos015839026

33. (4r)-(+)-4-benzyl-2-oxazolidinone

34. (r)-4-(phenylmethyl)-2-oxazolidinone

35. (r)-4-benzyl-2-oxazolidinone, 99%

36. Ac-1396

37. Bcp9000029

38. Cs-w007664

39. Fs-2114

40. (r)-(+/-)-4-benzyl-2-oxazolidinone

41. Bp-12372

42. Ds-14383

43. Smr000841429

44. Db-005017

45. A1783

46. Am20060480

47. (4r)-4-(phenylmethyl)-1,3-oxazolidin-2-one

48. 29b447

49. A1-00440

50. Q-102351

2.3 Create Date
2005-07-19
3 Chemical and Physical Properties
Molecular Weight 177.20 g/mol
Molecular Formula C10H11NO2
XLogP31.7
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count2
Rotatable Bond Count2
Exact Mass177.078978594 g/mol
Monoisotopic Mass177.078978594 g/mol
Topological Polar Surface Area38.3 Ų
Heavy Atom Count13
Formal Charge0
Complexity187
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag France
Digital Content Digital Content
142-08-5
Aliskiren
Established in 1990, Inabata France, a part of the Inabata Group, used to export chemical and pharmaceuti...
Established in 1990, Inabata France, a part of the Inabata Group, used to export chemical and pharmaceutical products to Japan. In 2006, it acquired Pharmasynthèse. Today, Inabata-Pharmasynthèse offers a wide range of services, including sourcing, manufacturing, and the development of raw materials for the pharmaceutical and cosmetic industries. It supplies these ingredients to Europe, Japan, and other countries. With expertise in fine chemical production, Inabata-Pharmasynthèse conducts manufacturing operations, ranging from pilot to commercial quantities, at its GMP-certified facility at St. Pierre-Les-Elbeuf in France.
Flag India
Digital Content Digital Content
142-08-5
Aliskiren
Aptra Synthesis Private Limited, is a reliable and vertically integrated manufacturer of APIs and interme...
Aptra Synthesis Private Limited, is a reliable and vertically integrated manufacturer of APIs and intermediates, boasting state-of-the-art manufacturing facilities that adhere to GMP standards. We take great pride in producing top-notch intermediates through our fully backward-integrated process. Aptra Synthesis Private Limited (ASPL) stands as one of the rapidly emerging manufacturers of Active Pharmaceutical Ingredients (APIs), Pellets (Semi-finished Formulations), and Intermediates.
Aptra Synthesis

IPS 2024

Not Confirmed

envelop Contact Supplier
Flag China
Digital Content Digital Content
URL Supplier Web Content
866030-35-5
Aliskiren
Dalian Richon Chem. Co., Ltd is a high-tech enterprise professionally involved in research and developmen...
Dalian Richon Chem. Co., Ltd is a high-tech enterprise professionally involved in research and development, manufacturing process and sales service of pharmaceutical intermediates and APIs. It has passed ISO9001:2000 international quality management system certificate. Its business scope includes development and manufacturing of APIs and pharmaceutical intermediates, contract development and manufacturing for domestic and international pharmaceutical companies, technical consultation, service and transfer.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
821-06-7
Aliskiren
Dalian Richon Chem. Co., Ltd is a high-tech enterprise professionally involved in research and developmen...
Dalian Richon Chem. Co., Ltd is a high-tech enterprise professionally involved in research and development, manufacturing process and sales service of pharmaceutical intermediates and APIs. It has passed ISO9001:2000 international quality management system certificate. Its business scope includes development and manufacturing of APIs and pharmaceutical intermediates, contract development and manufacturing for domestic and international pharmaceutical companies, technical consultation, service and transfer.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY